Alex FreemaninWintonCentreHow do people in the UK feel about easing the lockdown? Not ready yet?This week, the media story in the UK has been all about the potential to ease lockdown restrictions, with speculation about what the prime…May 9, 2020May 9, 2020
Alex FreemaninWintonCentreThe problems of a ‘bad test’ for COVID-19 antibodiesEveryone around the world is waiting for a COVID-19 antibody test that can finally allow those who have immunity (have developed…Apr 10, 20202Apr 10, 20202
Alex FreemaninWintonCentreHow different countries are reacting to the COVID-19 risk and their governments’ responsesWhen governments really need to get an urgent message across to the whole of society, and take what might be very unpopular measures, it’s…Mar 24, 2020Mar 24, 2020
Alex FreemaninWintonCentreFacts, risks and emotions:Has journalism and science communication crossed a line?Sep 26, 20183Sep 26, 20183
Alex FreemaninWintonCentreIs canakinumab really a wonder drug?This weekend’s health headlines were dominated by claims of a ‘wonder drug’ reducing heart attacks and ‘halving’ cancer.Aug 29, 20171Aug 29, 20171
Alex FreemaninWintonCentreCan ‘nine lifestyle changes’ change dementia risk?Today’s headlines across the media were resounding upbeat, following publication of an article in the Lancet.Jul 20, 2017Jul 20, 2017
Alex FreemaninWintonCentreIs the media now giving scientists lessons in research integrity?Journalists’ standards of statistical reporting have been notoriously low. But they are improving. And it seems they might now have become…May 11, 2017May 11, 2017
